Dernières nouvelles pour TherapeuticsMD (NASDAQ:TXMD) Stock

TherapeuticsMD

TherapeuticsMD Inc is a pharmaceutical royalty company, currently receiving royalties on products licensed to pharmaceutical organizations that possess commercial capabilities in the relevant territories. The company and its subsidiaries (i) granted Mayne Pharma an exclusive license to commercialize its IMVEXXY, BIJUVA and prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brands (collectively, the "Licensed Products") in the United States and its possessions and territories, (ii) assigned to Mayne Pharma its exclusive license to commercialize ANNOVERA (together with the Licensed Products, collectively, the "Products") in the United States and its possessions and territories.

TherapeuticsMD Inc

Press Releases

TherapeuticsMD Announces Second Quarter 2024 Financial Results

TherapeuticsMD Announces Third Quarter 2024 Financial Results

TherapeuticsMD Announces Full Year 2024 Financial Results

TXMD

Adial Pharmaceuticals, Inc - Common Stock

Adial Pharmaceuticals

Addex Therapeutics Ltd - American Depositary Shares

Addex Therapeutics

Artelo Biosciences

Aspire Biopharma Holdings, Inc. - Common Stock

Aspire Biopharma Hldgs

Athira Pharma

Biofrontera

Cocrystal Pharma

Citius Pharmaceuticals, Inc. - Common Stock

Citius Pharmaceuticals

Durect

Evoke Pharma

Gelteq

Hoth Therapeutics

Impact BioMedical

Kiora Pharmaceuticals, Inc. - Common Stock

Kiora Pharmaceuticals

Lexaria Bioscience

Lipocine

Lyra Therapeutics

Purple Biotech Ltd. - American Depositary Shares

Purple Biotech

ProPhase Labs

Rani Therapeutics Holdings, Inc. - Class A Common Stock

Rani Therapeutics Hldgs

SenesTech

Sonoma Pharmaceuticals, Inc. - Common Stock

Comments

TherapeuticsMD

Actualités

Dernières nouvelles pour TherapeuticsMD (NASDAQ:TXMD) Stock

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL